A carregar...
The impact of public coverage of newer hepatitis C medications on utilization, adherence, and costs in British Columbia
BACKGROUND: Sofosbuvir and ledipasvir-sofosbuvir are both newer direct-acting antiviral agents for the treatment of hepatitis C. The high list prices for both drugs have led to concern about the budget impact for public drug coverage programs. Therefore, we studied the impact of public prescription...
Na minha lista:
| Publicado no: | PLoS One |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7920374/ https://ncbi.nlm.nih.gov/pubmed/33647068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0247843 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|